RxDoctor Payments Data

Katherine Hall, MD

Family Medicine · Athens, TNNPI 1144575184

Payments from drug & device makers

$5,114in general payments, 2019–2025

Across 351 payments — averaging $14.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$727
  • GSK$660
  • Novo Nordisk$498
  • Amgen$286
  • AstraZeneca$270
  • Merck$267
  • plus $2K from 46 others

What the payments were for

  • Food & beverage$5,114100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,114 in reported general payments places this provider in the 80th percentile of 2,087 family medicine providers in Tennessee.

See all family medicine providers in Tennessee

Medicare billing

Part B allowed, 2024
$34,709
Medicare patients
108
Services billed
590

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide146$152,710
JardianceEmpagliflozin109$118,722
MounjaroTirzepatide97$114,146
EliquisApixaban125$111,941
OtezlaApremilast21$101,638
Trelegy ElliptaFluticasone/Umeclidin/Vilanter134$99,368
UbrelvyUbrogepant51$74,148
CreonLipase/Protease/Amylase24$57,939
MyrbetriqMirabegron66$44,867
GlyxambiEmpagliflozin/Linagliptin35$40,993
Breztri AerosphereBudesonide/Glycopyr/Formoterol50$39,672
FarxigaDapagliflozin Propanediol37$36,722
TradjentaLinagliptin21$30,558
Spiriva RespimatTiotropium Bromide46$28,978
TrulicityDulaglutide24$27,082

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Glyxambi, Tradjenta, Spiriva Respimat, Combivent Respimat$175$238,963240 claims
AbbVieUbrelvy, Creon, Qulipta, Linzess$727$184,692121 claims
Novo NordiskOzempic$498$152,710146 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta$660$144,275205 claims
Lilly USA, LLCMounjaro, Trulicity$140$141,228121 claims
PfizerEliquis$222$111,941125 claims
AmgenOtezla$286$101,63821 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort, Brilinta$270$96,444135 claims
Astellas Pharma US IncMyrbetriq$53$44,86766 claims
Otsuka America Pharmaceutical, Inc.Rexulti$90$20,28812 claims
Sumitomo Pharma America, Inc.Gemtesa$66$16,15013 claims
Johnson & JohnsonXarelto$110$14,71211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,087 family medicine providers in Tennessee.

Other family medicine in Athens

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →